Group One Trading, L.P. Sellas Life Sciences Group, Inc. Transaction History

Group One Trading, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.88 - $1.57 $163,992 - $292,577	186,355 New	186,355 $197,000
Q1 2022 May 12, 2022	SELL	$4.73 - $7.18 $26,383 - $40,050	-5,578 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$5.36 - $9.53 $29,630 - $52,681	5,528 Added 11056.0%	5,578 $31,000
Q3 2021 Nov 12, 2021	BUY	$8.21 - $10.53 $410 - $526	50 New	50 $0
Q2 2021 Aug 10, 2021	SELL	$7.19 - $13.71 $195,834 - $373,419	-27,237 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$5.5 - $11.71 $149,792 - $318,921	27,235 Added 1361750.0%	27,237 $233,000
Q4 2019 Feb 10, 2020	BUY	$3.79 - $10.5 $7 - $21	2 New	2 $0

5.69M

1.67M

74.7K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $21M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.